Drug Shortage Report for AURO-ABACAVIR/LAMIVUDINE

Last updated on 2020-04-15 History
Report ID 93077
Drug Identification Number 02454513
Brand name AURO-ABACAVIR/LAMIVUDINE
Common or Proper name abacavir; Lamivudine
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) ABACAVIR LAMIVUDINE
Strength(s) 600MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-09-04
Estimated end date
Actual end date 2020-04-14
Shortage status Resolved
Updated date 2020-04-15
Company comments
Health Canada comments
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2020-04-15 French Compare
v13 2020-04-15 English Compare
v12 2020-04-08 French Compare
v11 2020-04-08 English Compare
v10 2019-11-11 French Compare
v9 2019-11-11 English Compare
v8 2019-10-24 French Compare
v7 2019-10-24 English Compare
v6 2019-10-11 French Compare
v5 2019-10-11 English Compare
v4 2019-10-01 French Compare
v3 2019-10-01 English Compare
v2 2019-09-05 French Compare
v1 2019-09-05 English Compare